fda approval for semaglutide 🎉Exciting news that is now approved MASH (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Semaglutide shortage ends as FDA

Hunterbrook published a follow-up on the potential benefits to Hims from the nominee for FDA commissioner, who was chief medical officer of a telehealth company that sells compounded GLP-1s

Persistent vomiting, weight loss, black stools or severe pain need medical evaluation

It also gives your body time to adjust to each new dose

This code was added to ICD-10-CM to capture the rapidly growing use of these agents and distinguish them from both oral agents (Z79.84) and insulin (Z79.4)

Programs may include medical weight loss, semaglutide treatment, tirzepatide treatment, peptide therapy, and personalized wellness consultations

The Root Cause: What is Leaky Gut